News Focus
News Focus
Followers 843
Posts 122802
Boards Moderated 10
Alias Born 09/05/2002

Re: genisi post# 90

Tuesday, 08/07/2007 2:34:33 AM

Tuesday, August 07, 2007 2:34:33 AM

Post# of 4054
I think the answer is 2018 or 2019 for Herceptin (depending on which of two similar patents pertains) and 2019 for Avastin. However, I caution that, unlike small molecules—where the FDA’s Orange Book tells you everything you need to know—determining the end of patent protection for a biologic is fraught with pitfalls because one cannot be certain as to which patents will be prosecuted by the branded-drug company. Regards, Dew

“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent PLX News